Some have suggested that growth hormone is a wonder drug ( 16 ) that results in ripped muscle ( 17 ) and provides stamina-increasing properties ( 18 ) .
The use of human growth hormone to improve athletic performance has recently received worldwide attention .
This practice , often called sports doping , is banned by most professional sports leagues and associations , including the International Olympic Committee , Major League Baseball , and the National Football League ( 13 ) .
However , a wide range of athletes , including those from baseball ( 46 ) , cycling ( 7 , 8) , and track and field ( 5 , 9 ) , have been implicated in or have confessed to illicit growth hormone use .
The Mitchell report ( 10 ) recently identified 89 Major League Baseball players who allegedly used performance-enhancing drugs , and some of these players have subsequently admitted to using growth hormone ( 11 , 12 ) .
Part of the attraction of using growth hormone as a performance enhancer has been that its use is difficult to detect .
The World Anti-Doping Agency , whose formation stemmed from the widely publicized doping sc and al of the 1998 Tour de France ( 13 ) , first used a blood test to detect exogenous growth hormone during the 2004 Olympic Games in Athens .
Although growth hormone is reportedly used to enhance athletic performance and has been called the most anabolic substance known ( 15 ) , its efficacy for this purpose is not well established .
Exogenous growth hormone therapy in growth hormonedeficient adults ( that is , those with growth hormone deficiency due to hypothalamic or pituitary defects ) results in increased lean mass and decreased fat mass ( 19 ) , and comparable body composition changes are seen in healthy elderly adults who receive growth hormone ( 20 ) .
Some experts , however , have suggested that the strength-enhancing properties of growth hormone among healthy adults have been exaggerated ( 15 ) .
Serious side effects , including diabetes , hepatitis , and acute renal failure , may occur in athletes using high-dose growth hormone ( 21 ) .
Furthermore , the use of growth hormone for athletic enhancement is not approved by the U.S. Food and Drug Administration , and the distribution of growth hormone for this purpose is illegal in the United States ( 22 ) .
We performed a systematic review of r and omized , controlled trials to determine the effects of growth hormone therapy on athletic performance in healthy , physically fit , young adults .
Our primary aim was to evaluate the effects of growth hormone on body composition , strength , basal metabolism , and exercise capacity .
In addition , we sought to synthesize the evidence on adverse events associated with growth hormone in the healthy young and assess the quality of the published literature .
Potential parameters for the detection of hGH doping
The aim of our hGH application study with non-competitive athletes was the investigation of selected serum parameters from different processes affected by hGH . Fifteen athletes ( age 21–33 , mean 24 ) were treated with 0.06 IU hGH/kg BW per day or placebo ( 10 hGH , 5 placebo ) respectively for 14 days . Blood sample s were taken prior to , during and until 10 weeks after treatment . The concentrations of the following markers were determined in relevant serum sample s : IGF-I , IGFBP-3 , ALS , PIIINP , PINP , osteocalcin , and leptin . The IGF-I concentration increased rapidly within the hGH treatment group and showed significantly higher levels compared to baseline even 3 days after application . The response of the IGFBP-3 to the hGH applications was lower in comparison to IGF-I. The hGH group showed an increasing IGFBP-3 compared to baseline from day 4 till day 15 . The response of PIIINP to hGH is clearly delayed compared to the IGF-I axis , but the PIIINP concentration remains on an increased level for a longer period ( from day 4 until day 21 ) . The time course and the extent of response varied strongly interindividually . PINP and osteocalcin showed only a small response to hGH applications . These parameters are characterised by a strong scattering of base values compared with the small response . In the hGH treatment group very different leptin concentrations were found at the beginning of the study , but after treatment decreasing leptin levels were observed in all cases . The determination of only one parameter will not be sufficient for detection of hGH abuse . A combination of markers by mathematical methods can be helpful to distinguish between placebo and hGH-treated athletes . By using the suggested discriminant function the data sets of hGH and placebo-treated athletes could be separated without false positive results
Some have suggested that growth hormone is a wonder drug ( 16 ) that results in ripped muscle ( 17 ) and provides stamina-increasing properties ( 18 ) .
The use of human growth hormone to improve athletic performance has recently received worldwide attention .
This practice , often called sports doping , is banned by most professional sports leagues and associations , including the International Olympic Committee , Major League Baseball , and the National Football League ( 13 ) .
However , a wide range of athletes , including those from baseball ( 46 ) , cycling ( 7 , 8) , and track and field ( 5 , 9 ) , have been implicated in or have confessed to illicit growth hormone use .
The Mitchell report ( 10 ) recently identified 89 Major League Baseball players who allegedly used performance-enhancing drugs , and some of these players have subsequently admitted to using growth hormone ( 11 , 12 ) .
Part of the attraction of using growth hormone as a performance enhancer has been that its use is difficult to detect .
The World Anti-Doping Agency , whose formation stemmed from the widely publicized doping sc and al of the 1998 Tour de France ( 13 ) , first used a blood test to detect exogenous growth hormone during the 2004 Olympic Games in Athens .
Although growth hormone is reportedly used to enhance athletic performance and has been called the most anabolic substance known ( 15 ) , its efficacy for this purpose is not well established .
Exogenous growth hormone therapy in growth hormonedeficient adults ( that is , those with growth hormone deficiency due to hypothalamic or pituitary defects ) results in increased lean mass and decreased fat mass ( 19 ) , and comparable body composition changes are seen in healthy elderly adults who receive growth hormone ( 20 ) .
Some experts , however , have suggested that the strength-enhancing properties of growth hormone among healthy adults have been exaggerated ( 15 ) .
Serious side effects , including diabetes , hepatitis , and acute renal failure , may occur in athletes using high-dose growth hormone ( 21 ) .
Furthermore , the use of growth hormone for athletic enhancement is not approved by the U.S. Food and Drug Administration , and the distribution of growth hormone for this purpose is illegal in the United States ( 22 ) .
We performed a systematic review of r and omized , controlled trials to determine the effects of growth hormone therapy on athletic performance in healthy , physically fit , young adults .
Our primary aim was to evaluate the effects of growth hormone on body composition , strength , basal metabolism , and exercise capacity .
In addition , we sought to synthesize the evidence on adverse events associated with growth hormone in the healthy young and assess the quality of the published literature .